INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $294 | -20.8% | 9,312 | +2.4% | 0.00% | 0.0% |
Q2 2023 | $371 | -7.7% | 9,093 | -15.7% | 0.00% | 0.0% |
Q1 2023 | $402 | -12.2% | 10,781 | -17.9% | 0.00% | -25.0% |
Q4 2022 | $458 | -99.9% | 13,125 | +15.6% | 0.00% | -33.3% |
Q3 2022 | $635,000 | +10.2% | 11,352 | +2.0% | 0.01% | +20.0% |
Q2 2022 | $576,000 | -30.6% | 11,130 | -2.5% | 0.01% | -16.7% |
Q1 2022 | $830,000 | -71.4% | 11,420 | -53.5% | 0.01% | -45.5% |
Q4 2021 | $2,902,000 | +76.6% | 24,550 | +100.5% | 0.01% | -21.4% |
Q3 2021 | $1,643,000 | -15.9% | 12,245 | +1.5% | 0.01% | -12.5% |
Q2 2021 | $1,953,000 | +211.5% | 12,063 | +54.5% | 0.02% | -33.3% |
Q1 2021 | $627,000 | +47.2% | 7,810 | -0.3% | 0.02% | +50.0% |
Q4 2020 | $426,000 | – | 7,835 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |